SCHEMBL6002286

SCHEMBL6002286

[CH2]OC(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.61
ATM Q13315 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
NPSR1 Q6W5P4 3/20 0.56
CHRM3 P20309 5/20 0.49
CHRM4 P08173 4/20 0.49
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
CHRM1 P11229 4/20 0.46
CHRM5 P08912 3/20 0.46
CHRM2 P08172 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.42
PTGIR P43119 1/20 0.41
PTGDR Q13258 1/20 0.41
MEN1 O00255 3/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2092938 0.84 PTGIR (0.52) L3MBTL1ATMTDP1NPSR1PTGIR
SCHEMBL15518608 0.82 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL2092800 0.82 TDP1 (0.43) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL2249324 0.81 L3MBTL1 (0.65) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL2093369 0.79 ATM (0.41) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL5494234 0.79 L3MBTL1 (0.63) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL514386 0.78 SMN1; SMN2 (0.53) L3MBTL1NPSR1KMT2AALDH1A1NPC1
SCHEMBL2089002 0.78 ATM (0.40) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL4446206 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL15518997 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed